CORE LABORATORIES ANNOUNCES TIMING OF FOURTH QUARTER 2024 EARNINGS RELEASE AND CONFERENCE CALL
Werte in diesem Artikel
HOUSTON, Jan. 3, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its fourth quarter 2024 conference call for investors and analysts at 7:30 a.m. CST / 8:30 a.m. EST on January 30, 2025.
Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate Development and Investor Relations, will discuss financial and operational results. An earnings press release will be issued after market close on January 29, 2025 and may be accessed through the Company's website at www.corelab.com.
To register for the listen-only webcast, log on to www.corelab.com at least fifteen minutes prior to the start of the call. For those not available to listen to the live webcast, a replay and transcript will be available on the Company's website shortly after the call.
For conference call information, please contact Jenna Palfrey at jenna.palfrey@corelab.com for the dial-in number.
Core Laboratories Inc. (www.corelab.com) is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70 offices in more than 50 countries and is located in every major oil-producing province in the world.
View original content to download multimedia:https://www.prnewswire.com/news-releases/core-laboratories-announces-timing-of-fourth-quarter-2024-earnings-release-and-conference-call-302342143.html
SOURCE Core Laboratories Inc
Ausgewählte Hebelprodukte auf Core Laboratories NV
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Core Laboratories NV
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Core Laboratories NV
Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv
Analysen zu Core Laboratories NV
Datum | Rating | Analyst | |
---|---|---|---|
29.10.2018 | Core Laboratories NV Market Perform | Cowen and Company, LLC | |
10.10.2018 | Core Laboratories NV Underperform | Wolfe Research | |
07.09.2017 | Core Laboratories NV Outperform | RBC Capital Markets | |
21.04.2017 | Core Laboratories NV Buy | Loop Capital | |
13.12.2016 | Core Laboratories NV Neutral | UBS AG |
Datum | Rating | Analyst | |
---|---|---|---|
07.09.2017 | Core Laboratories NV Outperform | RBC Capital Markets | |
21.04.2017 | Core Laboratories NV Buy | Loop Capital | |
22.04.2016 | Core Laboratories NV Outperform | RBC Capital Markets | |
28.01.2016 | Core Laboratories NV Outperform | RBC Capital Markets | |
18.09.2015 | Core Laboratories NV Outperform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
29.10.2018 | Core Laboratories NV Market Perform | Cowen and Company, LLC | |
13.12.2016 | Core Laboratories NV Neutral | UBS AG | |
22.04.2016 | Core Laboratories NV Market Perform | Cowen and Company, LLC | |
12.01.2016 | Core Laboratories NV Perform | Oppenheimer & Co. Inc. | |
26.10.2015 | Core Laboratories NV Market Perform | Cowen and Company, LLC |
Datum | Rating | Analyst | |
---|---|---|---|
10.10.2018 | Core Laboratories NV Underperform | Wolfe Research |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Core Laboratories NV nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen